WTP for a QALY and health states: More money for severer health states?

被引：52
作者：
Shiroiwa T. [1 ]
Igarashi A. [2 ]
Fukuda T. [1 ]
Ikeda S. [3 ]
机构：
[1] Center for Public Health Informatics, National Institute of Public Health, Wako, Saitama 3510197
[2] Department of Drug Policy and Management, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 1130033
[3] Department of Pharmaceutical Sciences, School of Pharmacy, International University of Health and Welfare, Otawara, Tochigi 3248501
来源：
Cost Effectiveness and Resource Allocation | / 11卷 / 1期
关键词：
Cost-effectiveness analysis; Quality-adjusted life years; Threshold; Willingness-to-pay;
D O I：
10.1186/1478-7547-11-22
中图分类号：
学科分类号：
摘要：
Background: In economic evaluation, cost per quality-adjusted life year (QALY) is generally used as an indicator for cost-effectiveness. Although JPY 5 million to 6 million (USD 60, 000 to 75,000) per QALY is frequently referred to as a threshold in Japan, do all QALYs have the same monetary value?Methods: To examine the relationship between severity of health status and monetary value of a QALY, we obtained willingness to pay (WTP) values for one additional QALY in eight patterns of health states. We randomly sampled approximately 2,400 respondents from an online panel. To avoid misunderstanding, we randomly allocated respondents to one of 16 questionnaires, with 250 responses expected for each pattern. After respondents were asked whether they wanted to purchase the treatment, double-bounded dichotomous choice method was used to obtain WTP values.Results: The results clearly show that the WTP per QALY is higher for worse health states than for better health states. The slope was about JPY -1 million per 0.1 utility score increase. The mean and median WTP values per QALY for 16 health states were JPY 5 million, consistent with our previous survey. For respondents who wanted to purchase the treatment, WTP values were significantly correlated with household income.Conclusion: This survey shows that QALY based on the EQ-5D does not necessarily have the same monetary value. The WTP per QALY should range from JPY 2 million (USD 20,000) to JPY 8 million (USD 80,000), corresponding to the severity of health states. © 2013 Shiroiwa et al.; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 27 条
  • [1] Drummond M.F., Sculpher M.J., Torrance G.W., O'Brien B., Stoddart G.L., Methods for the economic evaluation of health care progrmmes 3rd edition, (2005)
  • [2] Gold M.R., Siegel J.E., Russell L.B., Weinstein M.C., Cost-effectiveness in health and medicine, (1996)
  • [3] Weinstein M.C., A QALY is a QALY is a QALY - or Is It?, J Health Econ, 7, 3, pp. 289-290, (1988)
  • [4] Dolan P., Shaw R., Tsuchiya A., Et al., QALY maximisation and people's preferences: a methodological review of the literature, Health Econ, 14, 2, pp. 197-208, (2005)
  • [5] Guide to the methods of technology appraisal, (2008)
  • [6] A new value-based approach to the pricing of branded medicines, (2010)
  • [7] Shah K.K., Severity of illness and priority setting in healthcare: a review of the literature, Health Policy, 93, 2-3, pp. 77-84, (2009)
  • [8] Nord E., Pinto J.L., Richardson J., Et al., Incorporating societal concerns for fairness in numerical valuations of health programmes, Health Econ, 8, 1, pp. 25-39, (1999)
  • [9] Shiroiwa T., Sung Y.K., Fukuda T., Et al., International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?, Health Econ, 19, 4, pp. 422-437, (2010)
  • [10] Donaldson C., Baker R., Mason H., Et al., The social value of a QALY: raising the bar or barring the raise?, BMC Health Serv Res, 11, (2011)
123